Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Advanced Solid Tumors 2Solid Tumors Refractory to Standard Therapy 1Solid Tumors 1Solid Tumor, Adult 1Solid Tumor 1Malignant Female Reproductive System Neoplasm 1KRAS Mutant Non-Small Cell Lung Cancer 1Advanced Solid Tumor 1

Interventions

palbociclib 1mirdametinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
KRAS Mutant Non-Small Cell Lung Cancer × palbociclib × Other solid neoplasm × Clear all
NCT02022982 2024-03-19

PALBOCICLIB + PD-0325901 for NSCLC & Solid Tumors

Dana-Farber Cancer Institute

Phase 1 Completed
60 enrolled
Other solid neoplasmThoracic

KRAS Mutant Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡